Protagenic Therapeutics, Inc.\new Cash Equivalents, at Carrying Value
Protagenic Therapeutics, Inc.\new (PTIX) had Cash Equivalents, at Carrying Value of $0 as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-19
- 2026-06-30: Cash Equivalents, at Carrying Value $0.00.
- 2026-03-31: Cash Equivalents, at Carrying Value $0.00.
- 2025-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2025-09-30: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-19 |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-19 |
| 2025-12-31 | $0.00 10-Q · filed 2026-03-09 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-26 |
| 2025-03-31 | $0.00 10-K · filed 2026-08-14 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-13 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-13 |
| 2015-12-31 | $0.00 10-K/A · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |